Knauer Joins UN Global Compact
Knauer (Berlin, Germany) has joined the United Nations Global Compact movement, underlining their commitment to responsible corporate governance on an international level.
Knauer (Berlin, Germany) has joined the United Nations Global Compact movement, underlining their commitment to responsible corporate governance on an international level.
The UN Global Compact is the world’s largest initiative for responsible corporate governance, involving more than 12,800 companies and organizations from more than 160 countries. The initiative aims to create an inclusive and sustainable global economy based on 10 universal principles, including: humans rights, labour standards, environmental protection, and corruption prevention.
Managing director and owner Alexandra Knauer signed the commitment letter to adhere to the 10 principles of the Global Compact in the presence of about 70 cooperation partners of the company. The “International Dealers Meeting 2018”, which took place at the company’s location in Berlin, formed the appropriate international and festive setting. The letter is personally addressed to UN SecretaryâGeneral António Guterres.
For more information please visit www.knauer.net and www.unglobalcompact.org
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.
